New ankle implant aims to get patients walking weeks sooner
NCT ID NCT06085586
First seen Nov 05, 2025 · Last updated Jun 20, 2026 · Updated 28 times
Summary
This study tests a new surgical implant called Fibulink for repairing ankle fractures with torn ligaments. The goal is to see if it allows patients to start walking fully at 4 weeks instead of the usual 6 weeks, without the implant failing. 56 adults with specific ankle injuries will be enrolled and followed for 6 months to check if the ankle stays properly aligned.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKLE FRACTURES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maimonides Medical Center
RECRUITINGBrooklyn, New York, 11219, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fibulink Syndesmosis Repair System (a surgical implant)
What this could lead to
If successful, this could allow patients to walk sooner after ankle surgery, potentially speeding up recovery and reducing long-term joint damage.
What could go wrong
This is a small, early-stage study with only 56 participants. The device may not maintain ankle alignment as hoped, and earlier weight bearing could increase the risk of implant failure or re-injury.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.